The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Open accessAbstract
Tumour-associated macrophages (TAMs) are enriched in glioblastoma multiformes (GBMs) that contain glioma stem cells (GSCs) at the apex of their cellular hierarchy. The correlation between TAM density and glioma grade suggests a supportive role for TAMs in tumour progression. Here we interrogated the molecular link between GSCs and TAM recruitment in GBMs and demonstrated that GSCs secrete periostin (POSTN) to recruit TAMs. TAM density correlates with POSTN levels in human GBMs. Silencing POSTN in GSCs markedly reduced TAM density, inhibited tumour growth, and increased survival of mice bearing GSC-derived xenografts. We found that TAMs in GBMs are not brain-resident microglia, but mainly monocyte-derived macrophages from peripheral blood. Disrupting POSTN specifically attenuated the tumour-supportive M2 type of TAMs in xenografts. POSTN recruits TAMs through the integrin αvβ₃ as blocking this signalling by an RGD peptide inhibited TAM recruitment. Our findings highlight the possibility of improving GBM treatment by targeting POSTN-mediated TAM recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Periostin (Postn) is shown to be required for alternative (less inflammatory) activation of microglia in brain tumors (Zhou et al., 2015).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Zhou et al., 2015
Experimental — accuracy not yet measuredIn the citing paper
“TD2 genes were well characterized for regulation of phagocytosis and microglial activation (e.g. Lgasl3; Rotshenker, 2009), microglial survival (e.g. Spp1; Rabenstein et al., 2016), alternative M2 activation of microglia (Zhou et al., 2015), and lysosomal proton pump (Atp6v0d2).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Zhou et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Crypt stem cells as the cells-of-origin of intestinal cancer
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., & Clevers, H. (2009) · Nature · doi:10.1038/nature07602 · Cited by 2,166
Cited by
Macrophages as regulators of tumour immunity and immunotherapy
DeNardo, D. G., & Ruffell, B. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0127-6 · Cited by 2,528
The Microenvironmental Landscape of Brain Tumors
Quail, D. F., & Joyce, J. A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.009 · Cited by 1,862
“, 2013), it is not surprising that activated TAMs have been shown to regulate glioma stem cell pools within the brain (Sarkar et al., 2014;Wu et al., 2010; Zhou et al., 2015).”
BackgroundThe role of microglia and macrophages in glioma maintenance and progression
Hambardzumyan, D., Gutmann, D. H., & Kettenmann, H. (2016) · Nature Neuroscience · doi:10.1038/nn.4185 · Cited by 1,683
Cancer stem cells in glioblastoma
Lathia, J. D., Mack, S. C., Mulkearns-Hubert, E. E., Valentim, C. L. L., & Rich, J. N. (2015) · Genes & Development · doi:10.1101/gad.261982.115 · Cited by 1,520
“CSCs located at the perivascular niche are in close contact with the endothelial cells (Calabrese et al. 2007), permitting engagement of endothelial cell Notch ligands with glioma CSC Notch receptors to activate Notch signaling, which supports self-renewal of glioma CSCs (Zhu et al. 2011).”
BackgroundTumor-associated macrophages: an accomplice in solid tumor progression
Chen, Y., Song, Y., Du, W., Gong, L., Chang, H., & Zou, Z. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0568-z · Cited by 1,096
Extracellular matrix and its therapeutic potential for cancer treatment
Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962
Cooper, J., & Giancotti, F. G. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.007 · Cited by 945
“In contrast, M2-like tumor-associated macrophages use the αvβ3 integrin to bind to periostin (POSTN) and home to the GBM stem cell niche (Zhou et al., 2015).”
BackgroundCancer stem cells as key drivers of tumour progression
Ayob, A. Z., & Ramasamy, T. S. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0426-4 · Cited by 910
Brain immunology and immunotherapy in brain tumours
Sampson, J. H., Gunn, M. D., Fecci, P. E., & Ashley, D. M. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0224-7 · Cited by 722
Friebel, E., Kapolou, K., Unger, S., Núñez, N. G., Utz, S., Rushing, E. J., Regli, L., Weller, M., Greter, M., Tugues, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.055 · Cited by 685
Macrophages and cancer: from mechanisms to therapeutic implications
Ostuni, R., Kratochvill, F., Murray, P. J., & Natoli, G. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.004 · Cited by 683
Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma
Chen, Z., Feng, X., Herting, C. J., Garcia, V. A., Nie, K., Pong, W. W., Rasmussen, R., Dwivedi, B., Seby, S., Wolf, S. A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2310 · Cited by 675
“Similarly, another study employed single staining with antibodies against either CX3CR1 or CCR2 to conclude that the majority of TAMs were monocyte-derived (CX3CR1−CCR2+) macrophages (38).”
ResultMüller, S., Kohanbash, G., Liu, S. J., Alvarado, B., Carrera, D., Bhaduri, A., Watchmaker, P. B., Yagnik, G., Di Lullo, E., Malatesta, M., et al. (2017) · Genome Biology · doi:10.1186/s13059-017-1362-4 · Cited by 654
“In glioma, TAMs comprise two populations: brainresident microglia, whose progenitors migrate to the central nervous system (CNS) during early development [5]; and macrophages that differentiate from bone marrow-derived monocytes, that have extravasated the blood–brain barrier [6].”
BackgroundChu, T., Wang, Z., Pe’er, D., & Danko, C. G. (2022) · Nature Cancer · doi:10.1038/s43018-022-00356-3 · Cited by 603
Saha, D., Martuza, R. L., & Rabkin, S. D. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.006 · Cited by 591
“GSCs induce and recruit M2-like TAMs (Wu et al., 2010; Zhou et al., 2015).”
BackgroundCancer Stem Cells: The Architects of the Tumor Ecosystem
Prager, B. C., Xie, Q., Bao, S., & Rich, J. N. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.12.009 · Cited by 587
“CSCs physically interact with M2 macrophages via ligand-receptor binding of CD90-CD11b and EphA4-Ephrin (Lu et al., 2014; Zhou et al., 2015).”
BackgroundInfluentialMultidimensional communication in the microenvirons of glioblastoma
Broekman, M. L., Maas, S. L. N., Abels, E. R., Mempel, T. R., Krichevsky, A. M., & Breakefield, X. O. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0025-8 · Cited by 579
Stem cell programs in cancer initiation, progression, and therapy resistance
Huang, T., Song, X., Xu, D., Tiek, D., Goenka, A., Wu, B., Sastry, N., Hu, B., & Cheng, S.-Y. (2020) · Theranostics · doi:10.7150/thno.41648 · Cited by 524
“Moreover, GSCs secrete periostin (POSTN) to recruit macrophages/monocytes and accelerate tumor growth; while M2 macrophages physically interact with mouse breast CSCs through ligand-receptor interactions of EphA4-Ephrin and CD90-CD11b [242, 243].”
BackgroundCancer stem cells: advances in knowledge and implications for cancer therapy
Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 553
Cancer stem cell–immune cell crosstalk in tumour progression
Bayik, D., & Lathia, J. D. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00366-w · Cited by 561
Glioblastoma: defining tumor niches
Hambardzumyan, D., & Bergers, G. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.10.009 · Cited by 522
“Furthermore, CSCs release the extracellular matrix protein periostin that accumulates in the perivascular tumor niche and acts as another chemoattractant for TAMs via integrin receptor αvβ3 signaling, facilitating the migration of macrophages to the niche [44].”
BackgroundGlioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer
Gimple, R. C., Bhargava, S., Dixit, D., & Rich, J. N. (2019) · Genes & Development · doi:10.1101/gad.324301.119 · Cited by 514
“GSCs down-regulate expression of innate immune sensors (namely, the toll-like receptor TLR4) to prevent negative modulation of stem-like properties by the immune system (Alvarado et al. 2017) and recruit TAMs that enhance tumor growth and block tumor rejection (Zhou et al. 2015; Otvos et al. 2016).”
BackgroundImmune microenvironment of gliomas
Gieryng, A., Pszczolkowska, D., Walentynowicz, K. A., Rajan, W. D., & Kaminska, B. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.19 · Cited by 538
A history of exploring cancer in context
Maman, S., & Witz, I. P. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0006-7 · Cited by 502
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalaf, K., Hana, D., Chou, J. T.-T., Singh, C., Mackiewicz, A., & Kaczmarek, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656364 · Cited by 513
Overcoming therapeutic resistance in glioblastoma: the way forward
Osuka, S., & Van Meir, E. G. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89587 · Cited by 511
LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment
Chen, C., He, W., Huang, J., Wang, B., Li, H., Cai, Q., Su, F., Bi, J., Liu, H., Zhang, B., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06152-x · Cited by 450
Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma
Bhaduri, A., Di Lullo, E., Jung, D., Müller, S., Crouch, E. E., Espinosa, C. S., Ozawa, T., Alvarado, B., Spatazza, J., Cadwell, C. R., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2019.11.015 · Cited by 419
“, 2017), and POSTN, a GSC secreted protein that recruits tumor associated macrophages that promote tumorigenesis (Zhou et al., 2015) (Fig 2B).”
BackgroundPlasticity of myeloid-derived suppressor cells in cancer
Tcyganov, E., Mastio, J., Chen, E., & Gabrilovich, D. I. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.009 · Cited by 398
Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages
Chen, D., Zhang, X., Li, Z., & Zhu, B. (2021) · Theranostics · doi:10.7150/thno.51777 · Cited by 390
“integrin αvβ3 to induce an M2 phenotype, and POSTN knockdown in GSCs inhibits tumor growth [67].”
BackgroundLin, H., Liu, C., Hu, A., Zhang, D., Yang, H., & Mao, Y. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01544-7 · Cited by 392
Lee, C. Y. D., Daggett, A., Gu, X., Jiang, L.-L., Langfelder, P., Li, X., Wang, N., Zhao, Y., Park, C. S., Cooper, Y., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.02.002 · Cited by 396
“TD2 genes were well characterized for regulation of phagocytosis and microglial activation (e.g., Lgals3; Rotshenker, 2009), microglial survival (e.g., Spp1; Rabenstein et al., 2016), alternative M2 activation of microglia (Postn; Zhou et al., 2015), and lysosomal proton pump (Atp6v0d2).”
BackgroundSelf-citationLiang, Z.-X., Liu, H.-S., Wang, F.-W., Xiong, L., Zhou, C., Hu, T., He, X.-W., Wu, X.-J., Xie, D., Wu, X.-R., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2077-0 · Cited by 361
Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data
Yang, W., Warrington, N. M., Taylor, S. J., Whitmire, P., Carrasco, E., Singleton, K. W., Wu, N., Lathia, J. D., Berens, M. E., Kim, A. H., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aao5253 · Cited by 348
“Six of the nine transcripts from this pathway [PLAT (33), CHL1 (34, 35), FERMT1 (36), PCDH8 (37), IGFBP2 (38, 39), and POSTN (40)] have known roles in glioma, and three (PLAT, IGFBP2, and POSTN) can distinguish proneural from classical high-grade glioma gene signatures (41).”
BackgroundThe Role of the Extracellular Matrix in Cancer Stemness
Nallanthighal, S., Heiserman, J. P., & Cheon, D.-J. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00086 · Cited by 344
Shi, Y., Ping, Y.-F., Zhou, W., He, Z.-C., Chen, C., Bian, B.-S.-J., Zhang, L., Chen, L., Lan, X., Zhang, X.-C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15080 · Cited by 344
Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma
DeCordova, S., Shastri, A., Tsolaki, A. G., Yasmin, H., Klein, L., Singh, S. K., & Kishore, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01402 · Cited by 346
Loh, J.-J., & Ma, S. (2024) · Cell Stem Cell · doi:10.1016/j.stem.2024.04.004 · Cited by 314
The Role of Hypoxia in Glioblastoma Invasion
Monteiro, A., Hill, R., Pilkington, G., & Madureira, P. (2017) · Cells · doi:10.3390/cells6040045 · Cited by 321
“Periostin Recruitment of M2 tumor-associated macrophages which are tumor-supportive and im unosuppressive [130].”
BackgroundChallenges in glioblastoma research: focus on the tumor microenvironment
Bikfalvi, A., da Costa, C. A., Avril, T., Barnier, J.-V., Bauchet, L., Brisson, L., Cartron, P. F., Castel, H., Chevet, E., Chneiweiss, H., et al. (2023) · Trends in Cancer · doi:10.1016/j.trecan.2022.09.005 · Cited by 302
Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection
Zhang, J., Chen, C., Li, A., Jing, W., Sun, P., Huang, X., Liu, Y., Zhang, S., Du, W., Zhang, R., et al. (2021) · Nature Nanotechnology · doi:10.1038/s41565-020-00843-7 · Cited by 305
Wang, X., Prager, B. C., Wu, Q., Kim, L. J. Y., Gimple, R. C., Shi, Y., Yang, K., Morton, A. R., Zhou, W., Zhu, Z., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.03.011 · Cited by 285
“TAMs secrete cytokines, including IL-6 and IL-10, which promote the glioblastoma proliferation and neo-vascularization (Samaras et al., 2007; Zhou et al., 2015).”
Self-citationHypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells
Colwell, N., Larion, M., Giles, A. J., Seldomridge, A. N., Sizdahkhani, S., Gilbert, M. R., & Park, D. M. (2017) · Neuro-Oncology · doi:10.1093/neuonc/now258 · Cited by 284
Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression
González-González, L., & Alonso, J. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00225 · Cited by 284
“Therefore, the interplay between glioma stem cells and tumor-associated macrophages can be modulated by POSTN and may be critical to promote glioblastoma tumor growth (118).”
BackgroundTargeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
Dong, Z., Zhang, G., Qu, M., Gimple, R. C., Wu, Q., Qiu, Z., Prager, B. C., Wang, X., Kim, L. J. Y., Morton, A. R., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0215 · Cited by 282
Phage display screening of therapeutic peptide for cancer targeting and therapy
Saw, P. E., & Song, E.-W. (2019) · Protein & Cell · doi:10.1007/s13238-019-0639-7 · Cited by 279
Yap, T. A., Tan, D. S. P., Terbuch, A., Caldwell, R., Guo, C., Goh, B. C., Heong, V., Haris, N. R. M., Bashir, S., Drew, Y., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0868 · Cited by 262
Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis
Cui, X., Morales, R.-T. T., Qian, W., Wang, H., Gagner, J.-P., Dolgalev, I., Placantonakis, D., Zagzag, D., Cimmino, L., Snuderl, M., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.053 · Cited by 267
“Furthermore, macrophages can degrade the ECM by producing proteases, such as metalloproteinase-9 (MMP-9), MMP-2, MMP-3, and excavating routes for EC proliferation and migration, and indirectly promoting angiogenic invasion and sprout formation [58].”
Tumor-initiating cells establish an IL-33–TGF-β niche signaling loop to promote cancer progression
Taniguchi, S., Elhance, A., Van Duzer, A., Kumar, S., Leitenberger, J. J., & Oshimori, N. (2020) · Science · doi:10.1126/science.aay1813 · Cited by 256
“Macrophages are known pro-tumorigenic immune cells and a major component of the TIC niche (39, 40), and previous studies showed that IL-33 can induce macrophage recruitment and alter their phenotype to resemble alternatively activated macrophages (41, 42).”
BackgroundGlioblastoma Therapy: Past, Present and Future
Obrador, E., Moreno-Murciano, P., Oriol-Caballo, M., López-Blanch, R., Pineda, B., Gutiérrez-Arroyo, J., Loras, A., Gonzalez-Bonet, L., Martinez-Cadenas, C., Estrela, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052529 · Cited by 271
Cancer Stemness Meets Immunity: From Mechanism to Therapy
Chen, P., Hsu, W.-H., Han, J., Xia, Y., & DePinho, R. A. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108597 · Cited by 252
Aging and cancer: The role of macrophages and neutrophils
Jackaman, C., Tomay, F., Duong, L., Abdol Razak, N. B., Pixley, F. J., Metharom, P., & Nelson, D. J. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.03.008 · Cited by 251
Otvos, B., Silver, D. J., Mulkearns-Hubert, E. E., Alvarado, A. G., Turaga, S. M., Sorensen, M. D., Rayman, P., Flavahan, W. A., Hale, J. S., Stoltz, K., et al. (2016) · Stem Cells · doi:10.1002/stem.2393 · Cited by 245
Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis
Poon, C. C., Sarkar, S., Yong, V. W., & Kelly, J. J. P. (2017) · Brain · doi:10.1093/brain/aww355 · Cited by 246
Ontogeny of Tumor-Associated Macrophages
Laviron, M., & Boissonnas, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01799 · Cited by 239
Kong, J., Tian, H., Zhang, F., Zhang, Z., Li, J., Liu, X., Li, X., Liu, J., Li, X., Jin, D., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1101-4 · Cited by 238
Macrophages and microglia: the cerberus of glioblastoma
Buonfiglioli, A., & Hambardzumyan, D. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01156-z · Cited by 238
“Periostin produced by GSCs was responsible for BMDM recruitment into the perivascular niche and enhanced glioma progression [93].”
BackgroundZhou, W., Chen, C., Shi, Y., Wu, Q., Gimple, R. C., Fang, X., Huang, Z., Zhai, K., Ke, S. Q., Ping, Y.-F., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.10.002 · Cited by 231
“…Cheng et al., 2013 N/A DesPro-GFP Cheng et al., 2013 N/A DesPro-HsvTK-GFP Cheng et al., 2013 N/A DesPro-Vec Cheng et al., 2013 N/A pCDH-Luciferase Zhou et al., 2015 N/A psPAX2 Addgene Cat# 12260 pCI-VSVG Addgene Cat# 1733 pLKO-shBMX1 Sigma-aldrich Cat# SHCLNG-NM_001721 TRCN0000006362 pLKO-shBMX2…”
MethodCao, H., Xu, M., Dong, W., Deng, B., Wang, S., Zhang, Y., Wang, S., Luo, S., Wang, W., Qi, Y., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30643 · Cited by 231
“Recently, studies have indicated that TAMs can switch their phenotype in response to the microenvironment, and M2 TAMs play a predominant role in tumor development.(35,36) Therefore, we sought to investigate the M2 TAMs in Apc mice after FMT.”
BackgroundXu, J., Zhang, J., Zhang, Z., Gao, Z., Qi, Y., Qiu, W., Pan, Z., Guo, Q., Li, B., Zhao, S., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03664-1 · Cited by 229
Combination therapy to checkmate Glioblastoma: clinical challenges and advances
Ghosh, D., Nandi, S., & Bhattacharjee, S. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0211-8 · Cited by 227
“Tumor-associated macrophages (TAMs) are enriched in GBMs and promote tumor progression [92].”
BackgroundGlioblastoma: Microenvironment and Niche Concept
Schiffer, D., Annovazzi, L., Casalone, C., Corona, C., & Mellai, M. (2018) · Cancers · doi:10.3390/cancers11010005 · Cited by 221
“GSCs secrete periostin that recruits M2 tumor-associated macrophages (TAMs) and promotes glioma growth through intergin αvβ3 [90].”
BackgroundCombined CSL and p53 downregulation promotes cancer-associated fibroblast activation
Procopio, M.-G., Laszlo, C., Al Labban, D., Kim, D. E., Bordignon, P., Jo, S.-H., Goruppi, S., Menietti, E., Ostano, P., Ala, U., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3228 · Cited by 223
“Interestingly, concomitant silencing of CSL and p53 resulted in over-induction of CAF marker genes like PTSG2 (Cox-2), with a critical role in inflammation 17 , and POSTN (periostin), a cancer-associated stromal matrix protein of importance for recruitment of macrophages to tumors 31 (Fig.”
JAK2-binding long noncoding RNA promotes breast cancer brain metastasis
Wang, S., Liang, K., Hu, Q., Li, P., Song, J., Yang, Y., Yao, J., Mangala, L. S., Li, C., Yang, W., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91553 · Cited by 223
“U937 monocytes were primed with 5 nM PMA (Sigma-Aldrich) for 48 hours to become monocyte-derived macrophages as described previously (47).”
MethodHarnessing the immune system in glioblastoma
Brown, N. F., Carter, T. J., Ottaviani, D., & Mulholland, P. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0258-8 · Cited by 223
Macrophage targeting in cancer
Lopez‐Yrigoyen, M., Cassetta, L., & Pollard, J. W. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14377 · Cited by 221
Glioma stem cells and their roles within the hypoxic tumor microenvironment
Boyd, N. H., Tran, A. N., Bernstock, J. D., Etminan, T., Jones, A. B., Gillespie, G. Y., Friedman, G. K., & Hjelmeland, A. B. (2021) · Theranostics · doi:10.7150/thno.41692 · Cited by 221
“Periostin secretion levels positively correlated with TAM numbers and silencing periostin in GSCs resulted in decreased TAM density, decreased tumor growth, and increased survival of mice bearing GSC-derived xenografts [29].”
BackgroundCancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma
Biserova, K., Jakovlevs, A., Uljanovs, R., & Strumfa, I. (2021) · Cells · doi:10.3390/cells10030621 · Cited by 220
“Glioma‐associated microglia/macrophages (GAMs) [25] mostly exhibit pro‐tumor ef‐ fects, as GSCs promote the M2 differentiation of GAMs through periostin secretion, which increases tumor growth via αvβ3 integrin [26,42,43].”
BackgroundTargeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
Fei, L., Ren, X., Yu, H., & Zhan, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.771210 · Cited by 219
Decoding the spatiotemporal heterogeneity of tumor-associated macrophages
Chu, X., Tian, Y., & Lv, C. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02064-1 · Cited by 214
“These factors, produced exclusively by CSCs, particularly perios-tin, are secreted preferentially by CSCs in glioblastomas and cholangiocarcinomas to enhance TAM recruitment [134, 135].”
BackgroundAdvancing to the era of cancer immunotherapy
Wang, Y., Wang, M., Wu, H., & Xu, R. (2021) · Cancer Communications · doi:10.1002/cac2.12178 · Cited by 214
Lamano, J. B., Lamano, J. B., Li, Y. D., DiDomenico, J. D., Choy, W., Veliceasa, D., Oyon, D. E., Fakurnejad, S., Ampie, L., Kesavabhotla, K., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2402 · Cited by 209
Liang, Z.-X., Liu, H.-S., Wang, F.-W., Xiong, L., Zhou, C., Hu, T., He, X.-W., Wu, X.-J., Xie, D., Wu, X.-R., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2661-3 · Cited by 209
Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
De Angelis, M. L., Francescangeli, F., La Torre, F., & Zeuner, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00626 · Cited by 206
He, Z., & Zhang, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741305 · Cited by 203
“Another study reported that periostin and collagen, both fibrosis-associated ECM components, respectively facilitated TAM recruitment via integrin binding (109) and promoted their M2-like polarization (110).”
BackgroundThe Role of Microglia and Macrophages in CNS Homeostasis, Autoimmunity, and Cancer
Yin, J., Valin, K. L., Dixon, M. L., & Leavenworth, J. W. (2017) · Journal of Immunology Research · doi:10.1155/2017/5150678 · Cited by 202
“Periostin has also emerged as an interesting target for attenuating the tumor-supportive phenotype of TAMs by interrupting integrin αvβ3 signaling [103].”
Wei, J., Chen, P., Gupta, P., Ott, M., Zamler, D., Kassab, C., Bhat, K. P., Curran, M. A., de Groot, J. F., & Heimberger, A. B. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz212 · Cited by 191
Jiang, S., Tian, G., Yang, Z., Gao, X., Wang, F., Li, J., Tian, Z., Huang, B., Wei, F., Sang, X., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.01.031 · Cited by 192
Glioma Stem Cells: Signaling, Microenvironment, and Therapy
Liebelt, B. D., Shingu, T., Zhou, X., Ren, J., Shin, S. A., & Hu, J. (2016) · Stem Cells International · doi:10.1155/2016/7849890 · Cited by 191
“Recently, Zhou et al. reported that GSCs secrete periostin (POSTN) to recruit TAMs to support glioblastoma progression [146].”
Schnittert, J., Bansal, R., Storm, G., & Prakash, J. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.020 · Cited by 188
“Similarly, the ECM protein periostin, secreted by glioblastoma stem cells, promote TAM recruitment to tumors via activation of αvβ3 [113].”
Binnemars‐Postma, K., Bansal, R., Storm, G., & Prakash, J. (2018) · The FASEB Journal · doi:10.1096/fj.201700629r · Cited by 185
“Recently, periostinwas shown tobe secreted by glioblastoma stem cells, which resulted in increased recruitment and differentiation of TAMs (34).”
BackgroundImmunotherapy for Glioblastoma: Current Progress and Challenges
Yu, M. W., & Quail, D. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.676301 · Cited by 185
“Interestingly, glioblastoma stem cells (GSCs) have been shown to recruit TAMs by secreting periostin and cytokines associated with alternative activation (80, 81).”
BackgroundThe Good and the Bad: Monocytes’ and Macrophages’ Diverse Functions in Inflammation
Austermann, J., Roth, J., & Barczyk-Kahlert, K. (2022) · Cells · doi:10.3390/cells11121979 · Cited by 183
Wang, J., Xu, S.-L., Duan, J.-J., Yi, L., Guo, Y.-F., Shi, Y., Li, L., Yang, Z.-Y., Liao, X.-M., Cai, J., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0285-z · Cited by 180
De Boeck, A., Ahn, B. Y., D’Mello, C., Lun, X., Menon, S. V., Alshehri, M. M., Szulzewsky, F., Shen, Y., Khan, L., Dang, N. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18569-4 · Cited by 180
Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide
Scodeller, P., Simón-Gracia, L., Kopanchuk, S., Tobi, A., Kilk, K., Säälik, P., Kurm, K., Squadrito, M. L., Kotamraju, V. R., Rinken, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14709-x · Cited by 179
“The M2 differentiation state is supported in part by the exposure to Th2 cytokines, such as IL-4 and IL-13, which results in (1) upregulation of the anti-inflammatory cytokine, IL-10, (2) decreased expression of pro-inflammatory cytokines, (3) amplification of metabolic pathways that suppress adaptive immune responses…”
Glioblastoma cancer stem cell biology: Potential theranostic targets
Sharifzad, F., Ghavami, S., Verdi, J., Mardpour, S., Mollapour Sisakht, M., Azizi, Z., Taghikhani, A., Łos, M. J., Fakharian, E., Ebrahimi, M., et al. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.003 · Cited by 175
An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy
Lu, L., Zhao, X., Fu, T., Li, K., He, Y., Luo, Z., Dai, L., Zeng, R., & Cai, K. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119666 · Cited by 176
Raggi, C., Correnti, M., Sica, A., Andersen, J. B., Cardinale, V., Alvaro, D., Chiorino, G., Forti, E., Glaser, S., Alpini, G., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.012 · Cited by 172
“Similar to normal stem cells, CSCs are believed to reside in specialized microenvironment (“CSC-niche”) within tumor-context [12-14] that supports self-renewal and drug-resistance [15-19].”
Guo, X., Xue, H., Shao, Q., Wang, J., Guo, X., Chen, X., Zhang, J., Xu, S., Li, T., Zhang, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11825 · Cited by 170
“A recent study showed that in gliomas, POSTN is mainly secreted by GSLCs [27].”
InfluentialPaul, R., Dorsey, J. F., & Fan, Y. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107985 · Cited by 168
Wu, B., Shi, X., Jiang, M., & Liu, H. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01748-4 · Cited by 169
“The expression of periostin on the cell membrane of CSCs recruits monocytes from the vasculature [85] and converts monocytes into TAMs in the TME to support the activity and survival of CSCs.”
BackgroundZhou, Q., Xian, M., Xiang, S., Xiang, D., Shao, X., Wang, J., Cao, J., Yang, X., Yang, B., Ying, M., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0259 · Cited by 168
“Glioma stem cells recruit TAMs and support the tumor-promoting M2 subtypes, indicating a preferential recruitment of peripheral macrophages (45).”
BackgroundZhang, X., Chen, L., Dang, W.-Q., Cao, M.-F., Xiao, J.-F., Lv, S.-Q., Jiang, W.-J., Yao, X.-H., Lu, H.-M., Miao, J.-Y., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-019-0345-3 · Cited by 163
Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas
Zeiner, P. S., Preusse, C., Golebiewska, A., Zinke, J., Iriondo, A., Muller, A., Kaoma, T., Filipski, K., Müller‐Eschner, M., Bernatz, S., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12690 · Cited by 162
Integrin Signaling in Glioma Pathogenesis: From Biology to Therapy
Ellert-Miklaszewska, A., Poleszak, K., Pasierbinska, M., & Kaminska, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030888 · Cited by 163
“Targeting these integrin receptors with the interfering RGD peptide (Arg-Gly-Asp-d-Phe-Lys) attenuated the interactions of microglia and macrophages with GSCs, reduced immune cell recruitment and their polarization into the tumor-supportive phenotype [93].”
BackgroundDual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma
Tao, W., Chu, C., Zhou, W., Huang, Z., Zhai, K., Fang, X., Huang, Q., Zhang, A., Wang, X., Yu, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16827-z · Cited by 162
Xu, Y., Qiu, Y., Zhang, B., Chen, G., Chen, Q., Wang, M., Mo, F., Xu, J., Wu, J., Zhang, R., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0152-9 · Cited by 168
The adaptive transition of glioblastoma stem cells and its implications on treatments
Wang, Z., Zhang, H., Xu, S., Liu, Z., & Cheng, Q. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00491-w · Cited by 182
“PN GSCs induce the formation of tumor-associated macrophages and recruit M2 tumor-associated macrophages.(36,157) Compared with MES GSCs, PN GSCs increase the expression of MHC I, CD40 and CD86 and downregulate the expression of MHC II and CD80.”
BackgroundFang, X., Zhou, W., Wu, Q., Huang, Z., Shi, Y., Yang, K., Chen, C., Xie, Q., Mack, S. C., Wang, X., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151673 · Cited by 163
“The cancer stem cell phenotypes of GSCs were validated by the expressions of GSC markers (SOX2, OLIG2, CD15, and L1CAM) and three functional assays (including in vitro limiting dilution assay, serum-induced cell differentiation assay, and in vivo tumorigenic assay) to assess the self-renewal potential, multilineage di…”
MethodInfluential
Metadata
- Authors
- Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., Rich, J. N., & Bao, S.
- Affiliations
- Cleveland Clinic (US)
- University Hospitals Cleveland Medical Center (US)
- Duke Medical Center (US)
- Corresponding author
- Bao, Shideng
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2015-01-12
- Volume
- 17
- Issue
- 2
- Pages
- 170-182
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC4312504
- OpenAlex
- W2073586533
- Cited by
- 940
- References
- 67
- Citations by year
- 2026: 29 · 2025: 74 · 2024: 93 · 2023: 101 · 2022: 118 · 2021: 117 · 2020: 93 · 2019: 82 · 2018: 71 · 2017: 81 · 2016: 50 · 2015: 30
- FWCI
- 38.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cleveland Clinic
- National Institutes of Health (1r01ns071996-01a1)
- National Institute of General Medical Sciences (T32GM007250)
- National Institute of Allergy and Infectious Diseases (T32AI089474)
- National Institute of Neurological Disorders and Stroke (R01-NS071996, R01NS070315)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- periostin, glioblastoma, glioma stem cells, tumour-associated macrophages, M2 macrophages, macrophage recruitment, integrin αvβ3, RGD peptide, monocyte-derived macrophages, tumor microenvironment, tumor growth, therapeutic target
- MeSH terms
- Animals, Brain Neoplasms, Cell Count, Chemotactic Factors, Female, Fluorescent Antibody Technique, Glioblastoma, Humans, Luminescent Measurements, Macrophages, Mice, Inbred C57BL, Monocytes, Neoplastic Stem Cells, Signal Transduction, Cell Adhesion Molecules, Survival Analysis, Gene Silencing, Xenograft Model Antitumor Assays, RNA, Small Interfering, Integrin alphaVbeta3, Cell Line, Tumor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.